Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Prostate cancer occurs when cells in the prostate gland undergo mutations in their DNA, causing them to grow uncontrollably and form a tumor. While the exact cause of these mutations remains under active research, a combination of age, family history, and genetic predispositions significantly influences the development of prostate cancer. What is the difference between causes and risk factors for prostate cancer? In medical terms, a "cause" is the direct trigger of a disease, while a "risk factor" increases the likelihood of developing it.
TL;DR: Prostate cancer occurs when cells in the prostate gland undergo mutations in their DNA, causing them to grow uncontrollably and form a tumor. While the exact cause of these mutations remains under active research, a combination of age, family history, and genetic predispositions significantly influences the development of prostate cancer.
In medical terms, a "cause" is the direct trigger of a disease, while a "risk factor" increases the likelihood of developing it. For prostate cancer, we rarely identify a single "cause" like a virus or toxin. Instead, prostate cancer development is a multi-step process where internal and external factors accumulate over time, leading to the transformation of healthy cells into malignant ones.
Yes, genetics play a pivotal role. About 5% to 10% of prostate cancer cases are thought to be hereditary. Specific gene mutations, such as those in the BRCA1 and BRCA2 genes—commonly associated with breast and ovarian cancer—are also linked to a higher risk of aggressive prostate cancer. Other inherited mutations, such as those in the HOXB13 gene, have also been identified as contributors to familial clusters of the disease.
While the exact etiology is still being mapped, the following factors are well-documented contributors to prostate cancer risk:
Researchers are currently utilizing "genomic profiling" to identify molecular signatures that distinguish indolent (slow-growing) prostate cancer from aggressive forms. By studying the tumor microenvironment and the role of chronic inflammation, scientists hope to move beyond broad risk factors to create personalized prevention and treatment strategies for the 15 members of the DiseaseMaps.org community and beyond.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.